Intensity modulated radiation therapy dose painting for localized prostate cancer using 11C-choline positron emission tomography scans

International Journal of Radiation Oncology Biology Physics

Volumn 83, Issue 5, 2012, Pages

  Chang, Joe H ^a,b   Lim Joon, Daryl ^a   Lee, Sze Ting ^a,b,c   Gong, Sylvia J ^a   Anderson, Nigel J ^a   Scott, Andrew M ^a,b,c   Davis, Ian D ^b,c   Clouston, David ^d   Bolton, Damien ^a,b   Hamilton, Christopher S ^a   Khoo, Vincent ^a,b,e  

^a AUSTIN HEALTH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

^d Focus Pathology   (Australia)

^e ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

11C choline; Dose painting; IMRT; Positron emission tomography; Prostate cancer

Indexed keywords

11C-CHOLINE; IMRT; INTENSITY-MODULATED RADIATION THERAPY; LOCALIZED PROSTATE CANCER; NORMAL TISSUE COMPLICATION PROBABILITIES; PET SCAN; PROSTATE CANCERS; RADICAL PROSTATECTOMY; STANDARDIZED UPTAKE VALUES; TECHNICAL FEASIBILITY; TUMOR CONTROL PROBABILITY;

DISEASES; PHYSICAL THERAPY; RADIOTHERAPY; TISSUE; TRANSMISSION CONTROL PROTOCOL; UROLOGY;

POSITRON EMISSION TOMOGRAPHY;

CHOLINE C 11;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; COHORT ANALYSIS; HUMAN; IMAGE PROCESSING; INTENSITY MODULATED RADIATION THERAPY; MALE; MULTIMODALITY CANCER THERAPY; POSITRON EMISSION TOMOGRAPHY; PRESCRIPTION; PRIORITY JOURNAL; PROBABILITY; PROSTATE CANCER; PROSTATECTOMY; RADIATION DOSE; TREATMENT PLANNING;

AGED; CARBON RADIOISOTOPES; CHOLINE; FEASIBILITY STUDIES; HUMANS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; ORGANS AT RISK; POSITRON-EMISSION TOMOGRAPHY; PROSTATE; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; RECTUM; TUMOR BURDEN;

EID: 84863625901     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2012.01.087     Document Type: Article

References (20)

1. G.A. Viani, E.J. Stefano, and S.L. Afonso Higher-than-conventional radiation doses in localized prostate cancer treatment: a meta-analysis of randomized, controlled trials Int J Radiat Oncol Biol Phys 74 2009 1405 1418
2. L.B. Marks, E.D. Yorke, and A. Jackson Use of normal tissue complication probability models in the clinic Int J Radiat Oncol Biol Phys 76 2010 S10 S19
3. C.C. Ling, J. Humm, and S. Larson Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality Int J Radiat Oncol Biol Phys 47 2000 551 560
4. D. Pucar, H. Hricak, and A. Shukla-Dave Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: magnetic resonance imaging and step-section pathology evidence Int J Radiat Oncol Biol Phys 69 2007 62 69
5. E.N. van Lin, J.J. Futterer, and S.W. Heijmink IMRT boost dose planning on dominant intraprostatic lesions: gold marker-based three-dimensional fusion of CT with dynamic contrast-enhanced and 1H-spectroscopic MRI Int J Radiat Oncol Biol Phys 65 2006 291 303
6. M. Pinkawa, C. Attieh, and M.D. Piroth Dose-escalation using intensity-modulated radiotherapy for prostate cancer-evaluation of the dose distribution with and without 18F-choline PET-CT detected simultaneous integrated boost Radiother Oncol 93 2009 213 219
7. J. Seppala, M. Seppanen, and E. Arponen Carbon-11 acetate PET/CT based dose escalated IMRT in prostate cancer Radiother Oncol 93 2009 234 240
8. 11C-choline PET scans for target volume definition in radical prostate radiotherapy Radiother Oncol 99 2011 187 192
9. Michalski JM, Purdy J, Bruner DW, et al. A phase III randomized study of high dose 3D-CRT/IMRT versus standard dose 3D-CRT/IMRT in patients treated for localized prostate cancer. RTOG 0126. Available at: http://www.rtog.org/ ClinicalTrials/ProtocolTable/StudyDetails.aspx?action=openFile&FileID=4589. Accessed Jan 1, 2012.
10. B. Warkentin, P. Stavrev, and N. Stavreva A TCP-NTCP estimation module using DVHs and known radiobiological models and parameter sets J Appl Clin Med Phys 5 2004 50 63
11. M. Zaider, and G.N. Minerbo Tumour control probability: a formulation applicable to any temporal protocol of dose delivery Phys Med Biol 45 2000 279 293
12. J.Z. Wang, M. Guerrero, and X.A. Li How low is the alpha/beta ratio for prostate cancer? Int J Radiat Oncol Biol Phys 55 2003 194 203
13. G.J. Kutcher, C. Burman, and L. Brewster Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations Int J Radiat Oncol Biol Phys 21 1991 137 146
14. J.M. Michalski, H. Gay, and A. Jackson Radiation dose-volume effects in radiation-induced rectal injury Int J Radiat Oncol Biol Phys 76 2010 S123 S129
15. M. Niyazi, P. Bartenstein, and C. Belka Choline PET based dose-painting in prostate cancer-modelling of dose effects Radiat Oncol 5 2010 23
16. M. Farsad, R. Schiavina, and P. Castellucci Detection and localization of prostate cancer: correlation of (11)C-choline PET/CT with histopathologic step-section analysis J Nucl Med 46 2005 1642 1649
17. 11C]choline PET/CT to localize prostate cancer depends on the tumor configuration Clin Cancer Res 17 2011 3751 3759
18. V. Fonteyne, G. Villeirs, and B. Speleers Intensity-modulated radiotherapy as primary therapy for prostate cancer: report on acute toxicity after dose escalation with simultaneous integrated boost to intraprostatic lesion Int J Radiat Oncol Biol Phys 72 2008 799 807
19. P.B. Morgan, A.L. Hanlon, and E.M. Horwitz Timing of biochemical failure and distant metastatic disease for low-, intermediate-, and high-risk prostate cancer after radiotherapy Cancer 110 2007 68 80
20. D.L. Longo New therapies for castration-resistant prostate cancer N Engl J Med 363 2010 479 481